Strategic Portfolio Management

From pipeline growth to
topline growth

Strategic precision for scientific innovation.

Our strategy and consulting services helps R&D decision makers align R&D efforts with market needs and regulatory demands and help create opportunities for portfolio leadership. We evaluate opportunities to help you maximize the value of your clinical assets through the entire drug lifecycle. We help deliver revenue mapped strategies for portfolio assessment, diversification, therapy area evaluation, and forecasting. 



We help you evaluate existing unmet needs, market accessibility, early Target Value Propositions (TVPs) to guide right R&D investments decisions.  



Forecast TVP revenue, drive planned investments across the full projected lifecycle.  



Evaluate new-to-market innovation proposals, develop trade-off management strategies to monitor portfolio health.